M1 macrophage predicted efficacy of neoadjuvant camrelizumab combined with chemotherapy vs chemotherapy alone for locally advanced ESCC: A pilot study

INTRODUCTION: The efficacy and safety of immunotherapy have been widely recognized in gastrointestinal-related cancers. However, the efficacy of neoadjuvant camrelizumab for locally advanced esophageal squamous cell carcinoma (ESCC) has not been firmly established. This study compared the efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shu, Xu, Guanghui, Li, Mengbin, Zheng, Jiyang, Wang, Yuhao, Feng, Xiangying, Luo, Jialin, Wang, Shibo, Liu, Huan, Duan, Weiming, Zhang, Hushan, Huang, Depei, Zhao, Feilong, Nie, Yongzhan, Yang, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038194/
https://www.ncbi.nlm.nih.gov/pubmed/36969032
http://dx.doi.org/10.3389/fonc.2023.1139990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038194/
https://www.ncbi.nlm.nih.gov/pubmed/36969032
http://dx.doi.org/10.3389/fonc.2023.1139990

Ejemplares similares